Wellington Partners appoints Essig as venture partner

Prior to joining Wellington, Essig served as a board member on various US life sciences companies. Essig has a background in medical technology and healthcare investment banking. His appointment will strengthen the VC's footprint in the US.

The new venture partner currently serves as chairman of the board of directors of Integra Life Sciences following a 15-year stint as the company's CEO. Prior to Integra, Essig was managing director at Goldman Sachs, supervising the firm's medical technology practice. His board experience includes St Jude Medical Corporation, Breg, Zimmer Holdings and Vital Signs.

Wellington is a pan-European VC firm with offices in Munich, London and Zurich. The firm has more than €800m of assets under management in the life sciences, digital media and resource efficiency sectors. Its latest fund, Wellington Partners IV Life Science, held its first closing in September and is expected to reach €120m.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• Wellington Partners